References
- Johanson JF. Review of the treatment options for chronic constipation. Med Gen Med 2007;9:25
- Longstreth GF, Thompson WG, Chey WD, et al. Functional bowel disorders. Gastroenterology 2006;130:1480-91
- Higgins PD, Johnanson JF. Epidemiology of constipation in North America: a systematic review. Am J Gastroenterol 2004;99:750-9
- Chang L. Impact of chronic constipation and IBS. Adv Stud Med 2006;6:S49-57
- Lembo AJ, Camilleri M. Chronic constipation. N Engl J Med 2003;349:1360-8
- World Gastroenterology Organisation Global Guidelines. Coping with common GI symptoms in the community—A global perspective on heartburn, constipation, bloating, and abdominal pain/discomfort. Milwaukee, WI, USA: World Gastroenterology Organisation. 2013. http://www.worldgastroenterology.org/assets/export/userfiles/2013_FINAL_Common%20GI%20Symptoms%20_long.pdf. Accessed August 2, 2013
- American College of Gastroenterology Chronic Constipation Task Force. An evidence-based approach to the management of chronic constipation in North America. Am J Gastroenterol 2005;100(Suppl 1):S1-4
- Nyrop KA, Palsson OS, Levey RL, et al. Costs of health care for irritable bowel syndrome, chronic constipation, functional diarrhea and functional abdominal pain. Aliment Pharmacol Ther 2007;26:237-48
- Choung RS, Branda ME, Chitkara D, et al. Longitudinal direct costs associated with constipation in women. Aliment Pharmacol Ther 2011;33:251-60
- Mitra D, Davis KL, Baran RW. All-cause health care charges among managed care patients with constipation and comorbid irritable bowel syndrome. Postgrad Med 2011;123:122-32
- Segel JE. Cost of illness studies—A primer. Research Triangle Park, NC, USA: RTI International. 2006. http://www.amcp.org/WorkArea/DownloadAsset.aspx?id=12960. Accessed February 28, 2013
- Sun SX, DiBonaventura M, Purayidathil FW, et al. Impact of chronic constipation on health-related quality of life, work productivity, and healthcare resource use: an analysis of the National Health and Wellness Survey. Dig Dis Sci 2011;56:2688-95
- Akobundu E, Ju J, Blatt L, et al. Cost-of-illness studies: a review of current methods. Pharmacoeconomics 2006;24:869-90
- Leider HL, Dhaliwal J, Davis EJ, et al. Healthcare costs and nonadherence among chronic opioid users. Am J Manag Care 2011;17:32-40.
- Elixhauser A, Steiner C, Harris DR, et al. Comorbidity measures for use with administrative data. Med Care 1998;36:8-27
- Manning WG, Basu A, Mullahy J. Generalized modeling approaches to risk adjustment of skewed outcomes data. J Health Econ 2005;24:465-88
- Glick H, Doshi J. Applications of statistical considerations in health economic evaluation. Short course presented at: International Society for Pharmacoeconomics and Outcomes Research 16th Annual International Meeting; May 22, 2011; Baltimore, MD
- Basu A, Rathouz PJ. Estimating marginal and incremental effects on health outcomes using flexible link and variance function models. Biostat 2005;6:93-109
- Lipton RB, Bigal ME, Diamond M, et al. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 2007;68:343-9
- Hawkins K, Wang S, Rupnow M. Direct cost burden among insured US employees with migraine. Headache 2008;48:553-63
- Barnett SB, Nurmagambetoy TA. Costs of asthma in the United States: 2002-2007. J Allergy Clin Immunol 2011;127:145-52
- Sullivan PW, Ghushchyan VH, Slejko JF, et al. The burden of adult asthma in the United States: Evidence from the Medical Expenditure Panel Survey. J Allergy Clin Immunol 2011;127:363-9